HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Rappocciolo, G. Articles by Ellis, S. A. Search for Related Content PubMed PubMed Citation Articles by Rappocciolo, G. Articles by Ellis, S. A. Agricola Articles by Rappocciolo, G. Articles by Ellis, S. A.

Down-regulation of MHC class I expression by equine herpesvirus-1

Giovanna Rappocciolo

Department of Immunology and Pathology, Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN, UK

Correspondence
Shirley Ellis
shirley.ellis{at}bbsrc.ac.uk

There is good evidence that cytotoxic T lymphocytes play an important role in the clearance of equine herpesvirus-1 (EHV1) in horses. We have demonstrated that, in common with other alphaherpesviruses, EHV1 infection can lead to dramatic down-regulation of MHC class I expression at the cell surface, a common strategy for pathogen evasion of the host immune response. This down-regulation is specific for MHC class I and does not reflect a general shut-off of host-cell protein synthesis. The use of monoclonal antibodies that recognize different MHC class I epitopes has demonstrated that the effect may be allele- or locus-specific. Use of the viral DNA synthesis inhibitor phosphonoacetic acid, which prevents late viral gene expression, showed that the effect is mediated by an immediate-early or early viral gene, and use of the protein translation inhibitor cycloheximide confirmed that an early gene is primarily responsible. The data indicate that EHV1 infection results in enhanced endocytosis of MHC class I from the cell surface; the only other herpesvirus reported to use this mechanism is human herpesvirus-8. Elucidation of the precise mechanisms used by EHV1 in this process and identification of the genes responsible may lead to improved vaccination strategies.

Present address: Department of Infectious Disease and Microbiology, Graduate School of Public Health, Pittsburgh, USA.

This article has been cited by other articles:

				J. H. Kydd, N. J. Davis-Poynter, J. Birch, D. Hannant, J. Minke, J.-C. Audonnet, D. F. Antczak, and S. A. Ellis A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1 J. Gen. Virol., September 1, 2006; 87(9): 2507 - 2515. [Abstract] [Full Text] [PDF]

				D. Koppers-Lalic, E. A. J. Reits, M. E. Ressing, A. D. Lipinska, R. Abele, J. Koch, M. M. Rezende, P. Admiraal, D. van Leeuwen, K. Bienkowska-Szewczyk, et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing PNAS, April 5, 2005; 102(14): 5144 - 5149. [Abstract] [Full Text] [PDF]

				A. P. N. Ambagala, R. S. Gopinath, and S. Srikumaran Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1 J. Gen. Virol., February 1, 2004; 85(2): 349 - 353. [Abstract] [Full Text] [PDF]

				J. L. Petersen, C. R. Morris, and J. C. Solheim Virus Evasion of MHC Class I Molecule Presentation J. Immunol., November 1, 2003; 171(9): 4473 - 4478. [Full Text] [PDF]